Close search

The Science Behind DoseMe

Bayesian Dosing - From Research to Clinical Practice

How does Bayesian Dosing work?

Bayesian dosing uses patient data and laboratory results to estimate a patient's ability to absorb, process, and clear a drug from their system. Using a published population model, DoseMe's algorithms adjusts the pharmacokinetic and/or pharmacodynamic parameters so that a patient-specific, individualised drug model is built. This individual model is then used to provide a patient-specific dosing recommendation to reach a therapeutic target.

Where there is no laboratory results yet available, DoseMe can use a population model with individual patient details (age, height, weight, sex, even genotype if available) to calculate an initial dose estimate.

Where has it been used?

Bayesian dose forecasting has been used extensively around the world, although its use in a clinical setting has been previously isolated to pockets of clinicians who were familiar with the technology and had a good understanding of both IT and mathematics.

DoseMe no longer requires users to be IT experts, making it easy for clinicians to use, and allows for a collaborative team approach to therapy that can be implemented out of the box.

Bayesian Dosing Benefits

Interested to learn more about the benefits of Bayesian dosing? Studies have shown significant improvements to mortality, risk and patient outcomes.

Find out more

Schedule a personal demonstration

See how easy DoseMe is to operate and integrate into your workday.

Schedule your one-on-one demonstration below. You can also phone us on +61 7 3151 3033 or email hello@doseme.com.au.

Privacy policy | Copyright © 2012 - 2017 DoseMe Pty Ltd. All Rights Reserved. DoseMe® is a registered trademark of DoseMe Pty Ltd.